<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>药物简讯 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-11-26T16:22:22+08:00</updated>
  <subtitle>【国内外药讯，医药市场，医药数据分享】</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>美年大健康旗下美因基因完成超5.4亿元股权转让，拟独立上市</title>
    <updated>2020-11-26T14:54:48+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-26:/s/yZcn-JkpGcNAAkJ33A5bhg</id>
    <link href="https://mp.weixin.qq.com/s/yZcn-JkpGcNAAkJ33A5bhg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>阿斯利康中国与华亘控股达成战略合作</title>
    <updated>2020-11-26T14:54:48+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-26:/s/8plNi4czMuk3et-UQNPXeg</id>
    <link href="https://mp.weixin.qq.com/s/8plNi4czMuk3et-UQNPXeg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>先健科技子公司元心科技完成1.6亿元A轮融资，IDG领投</title>
    <updated>2020-11-26T14:54:48+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-26:/s/baMAssJ6LJYVK2bVUA1eOg</id>
    <link href="https://mp.weixin.qq.com/s/baMAssJ6LJYVK2bVUA1eOg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>BioNTech和InstaDeep宣布战略合作并成立AI创新实验室开发新型免疫疗法</title>
    <updated>2020-11-26T14:54:48+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-26:/s/Wv3JksraStj3QyTpvIxr7Q</id>
    <link href="https://mp.weixin.qq.com/s/Wv3JksraStj3QyTpvIxr7Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>BD福音|Astellas公开出售8款在研新药项目</title>
    <updated>2020-11-26T14:54:48+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-26:/s/_Dth4X3FuzakC_fLf2ggpw</id>
    <link href="https://mp.weixin.qq.com/s/_Dth4X3FuzakC_fLf2ggpw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>百奥泰向EMA递交贝伐珠单抗注射液上市许可申请</title>
    <updated>2020-11-26T14:54:48+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-26:/s/CORRXnJ4hnTLSof8F_jUfw</id>
    <link href="https://mp.weixin.qq.com/s/CORRXnJ4hnTLSof8F_jUfw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>远大医药两款全球创新核药产品上市申请获受理</title>
    <updated>2020-11-26T14:54:48+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-26:/s/xCYWrtZd-DCHpQNA9CuyQg</id>
    <link href="https://mp.weixin.qq.com/s/xCYWrtZd-DCHpQNA9CuyQg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>王晓东院士实验室发现抑制睾丸衰老的新机制</title>
    <updated>2020-11-25T17:11:47+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-25:/s/WGQYUv7w5pONe8hFKhSTvA</id>
    <link href="https://mp.weixin.qq.com/s/WGQYUv7w5pONe8hFKhSTvA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>BD交易|不超7.68亿美元，复宏汉霖授权旗下一款双抗海外权益</title>
    <updated>2020-11-25T17:11:47+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-25:/s/7mHrYoqh8ofLVMLVR35uTA</id>
    <link href="https://mp.weixin.qq.com/s/7mHrYoqh8ofLVMLVR35uTA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>君实生物Trop2-ADC进入I期临床，完成首例患者给药</title>
    <updated>2020-11-25T17:11:47+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-25:/s/M8IIpOjayiIuyg_M9MD4rQ</id>
    <link href="https://mp.weixin.qq.com/s/M8IIpOjayiIuyg_M9MD4rQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>安科生物HER2单抗获批临床治疗HER过表达实体瘤</title>
    <updated>2020-11-25T17:11:47+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-25:/s/r3VkhD0xNkK2vVlFxoWFaw</id>
    <link href="https://mp.weixin.qq.com/s/r3VkhD0xNkK2vVlFxoWFaw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>估值百亿元！艾力斯上市募资20亿元，核心产品伏美替尼年内获批</title>
    <updated>2020-11-25T17:11:47+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-25:/s/Z9XOnHCUk4AFg4DtmzeFIg</id>
    <link href="https://mp.weixin.qq.com/s/Z9XOnHCUk4AFg4DtmzeFIg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>扬子江药业引进8款生物仿制药中国区商业化权益</title>
    <updated>2020-11-25T17:11:47+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-25:/s/dymKEdlKHa3I3XtjNBUtTQ</id>
    <link href="https://mp.weixin.qq.com/s/dymKEdlKHa3I3XtjNBUtTQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>继药明康德后，复星医药4000万美元认购Pontifax新基金LP份额</title>
    <updated>2020-11-25T17:11:47+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-25:/s/uC5OYiZgJwEsc3rr2RsyLQ</id>
    <link href="https://mp.weixin.qq.com/s/uC5OYiZgJwEsc3rr2RsyLQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>再极医药申报小分子PD-L1抑制剂MAX-10181片临床试验</title>
    <updated>2020-11-24T17:16:56+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-24:/s/YkGGFeeRzssWkjgnC17Liw</id>
    <link href="https://mp.weixin.qq.com/s/YkGGFeeRzssWkjgnC17Liw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>石药集团同类首创Claudin18.2-ADC新药获FDA授予胃癌孤儿药资格</title>
    <updated>2020-11-24T17:16:56+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-24:/s/kZ_wpVtMOVfJ5oKuncDzsg</id>
    <link href="https://mp.weixin.qq.com/s/kZ_wpVtMOVfJ5oKuncDzsg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>扬子江上海海雁医药申报第6款小分子新药YZJ-3058片临床申请</title>
    <updated>2020-11-24T17:16:56+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-24:/s/xC8CRjfFGXNvmtg6__j2kw</id>
    <link href="https://mp.weixin.qq.com/s/xC8CRjfFGXNvmtg6__j2kw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>又一款BTK抑制剂SS-001胶囊申报临床</title>
    <updated>2020-11-24T17:16:56+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-24:/s/MTkgJgy1ibcs0bxiRpqVyg</id>
    <link href="https://mp.weixin.qq.com/s/MTkgJgy1ibcs0bxiRpqVyg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>FDA批准了罕见的儿童衰老性疾病首款新药上市</title>
    <updated>2020-11-24T17:16:56+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-24:/s/DhNVMggPp7EqBMKKWCz-yA</id>
    <link href="https://mp.weixin.qq.com/s/DhNVMggPp7EqBMKKWCz-yA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>全球商业化加速，为何看好基石药业PD-L1抗体舒格利单抗？</title>
    <updated>2020-11-24T17:16:56+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-24:/s/EE7gWJFe8M5thWz8hdkZPQ</id>
    <link href="https://mp.weixin.qq.com/s/EE7gWJFe8M5thWz8hdkZPQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>